Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06235203 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 1, 2024 to Jul 9, 2024
    • Site contacts updated at 7 of 7 sites
    v4
  2. Eligibility criteria shortened, about 25 words
    • Site details revised at 7 of 7 sites
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to May 1, 2024
    • Site details revised at 7 of 7 sites
    • Eligibility criteria expanded, about 2 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multicenter randomized controlled study of surgery combined with neoadjuvant and adjuvant therapy for locally advanced recurrent nasopharyngeal carcinoma in comparison to surgery combined with adjuvant therapy
Trial Details
NCT Number NCT06235203
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, Shenzhen Second People's Hospital
Conditions
(from sponsor)		 Recurrent Nasopharyngeal Carcinoma
Related terms Nasopharyngeal Carcinoma
Enrollment 154 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov